OB/GYN and Women's Health - Global Women's Health Academy

1-16 of 195

Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Project Oncology®
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS; Adam Brufsky, MD, PhD
- Alexandria May, PharmD, BCPS
- Adam Brufsky, MD, PhD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP; Neil M. Iyengar, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Neil M. Iyengar, MD
- Sarah H. Donahue, MPH, NP
Protecting Heart Health in Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
The Past, Present, and Future of Metastatic Breast Cancer Care
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
The Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
Addressing Unmet Needs in First-Line mTNBC Care
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast Cancer
Addressing Unmet Needs in First-Line mTNBC Care
Jennifer Caudle, DO, FACOFP; Alexis Ann LeVee, MD
- Jennifer Caudle, DO, FACOFP
- Alexis Ann LeVee, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Maxwell Llyod, MD; Ryan Quigley
- Maxwell Llyod, MD
- Ryan Quigley
Understanding Crossover and Endpoints in ASCENT-03 and -04
Understanding Crossover and Endpoints in ASCENT-03 and -04
Project Oncology®
Understanding Crossover and Endpoints in ASCENT-03 and -04
Jennifer Caudle, DO, FACOFP; Neil M. Iyengar, MD
- Jennifer Caudle, DO, FACOFP
- Neil M. Iyengar, MD
Improving Pain Management During Intrauterine Device Insertion
Improving Pain Management During Intrauterine Device Insertion
Advances in Women's Health
Improving Pain Management During Intrauterine Device Insertion
Alexandria May, PharmD, BCPS; Mitchell D. Creinin, MD
- Alexandria May, PharmD, BCPS
- Mitchell D. Creinin, MD
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Advances in Women's Health
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA; Mary Jane Minkin, MD
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Mary Jane Minkin, MD
Managing Perimenopausal Bleeding with Evidence-Based Options
Managing Perimenopausal Bleeding with Evidence-Based Options
Advances in Women's Health
Managing Perimenopausal Bleeding with Evidence-Based Options
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA; Monica Christmas, MD
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Monica Christmas, MD
- Mary Jane Minkin, MD
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
- Ryan Quigley
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Does BMI Matter in mBC Outcomes?
Does BMI Matter in mBC Outcomes?
Project Oncology®
Does BMI Matter in mBC Outcomes?
Predicting Breast Cancer Metastasis with Proteomics
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®
Predicting Breast Cancer Metastasis with Proteomics
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP; Heather Parsons
- Charles Turck, PharmD, BCPS, BCCCP
- Heather Parsons

Prev
1
2
3
…
12
13
Next

1/6